Irreversible electroporation: Implications for prostate ablation

Technology in Cancer Research and Treatment

Volumn 6, Issue 4, 2007, Pages 295-300

  Onik, Gary ^b,c   Mikus, Paul ^b   Rubinsky, Boris ^a,b,d  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b Oncobionic Inc   (United States)

^c FLORIDA HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; CRYOABLATION; DOG; ELECTROPORATION; NONHUMAN; PROSTATE CANCER; THERMAL INJURY;

EID: 34548361337     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460700600405     Document Type: Article

References (8)

1. Health Care Financing Administration. Medicare Coverage Policy: Decisions. Bagley, G. P. Cryosurgery ablation of the prostate (#CAG-00031). Available at: http://www.hcfa.gov/coverage/8b3-f1.htm. Accessed November 7, 2001.
2. Bahn, D. K., Lee, F., Bandalament, R., et al. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 60 (2 Suppl 1), 3-11 (2002).
3. Rubinsky, B., Onik, G., Mikus, P. Irreversible electroporation: a new ablation modality - clinical implications. Technol Cancer Res Treat 6, 37-48 (2007).
4. Neumann, E., Schaefer-Ridder, M., Wang, Y., Hofschneider, P. H. et al. Gene transfer into mouse lyoma cells by electroporation in high electric fields. J EMBO 1, 841-845 (1982).
5. Mir, L. M., Belehradek, M., Domenge, C., Luboniski, B., Orlowski, S. Belehradek, J., Schwaab, B., Luboniski, B., Paoletti, C. Electrochemotherapy, a novel antitumor treatment: first clinical trial. C R Acad Sci III 313, 613-618 (1991).
6. Davalos, R. V., Mir, L. M., and Rubinsky, B. Tissue ablation with irreversible electroporation. Annals of Biomedical Engineering 33, 223-231 (2005).
7. Tanaka, S. Immunological aspects of cryosurgery in general surgery. Cryobiology 19, 247-262 (1982).
8. Miller, L., Leor, J., and Rubinsky, B. Cancer cells ablation with irreversible electroporation. Technology in Cancer Research and Treatment 4, 699-105 (2005).